Scholar Rock Sees Phase III Path For SMA Drug
Apitegromab Being Studied As Monotherapy And In Combination
While the drug may be well-positioned for registrational development, some important caveats remain after mixed data in Phase II study cohorts.
While the drug may be well-positioned for registrational development, some important caveats remain after mixed data in Phase II study cohorts.